PATENT CLAIM ANALYSIS

Application Number: 15938837
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["514", "399000"]

Abstract:
Methods and formulations of modified release amino acids are provided for the treatment or management of diseases defined by impaired amino acid metabolism, with improved pharmacokinetics, metabolism and utilization.

Claim (Index 11):
The formulation of  claim 10 , comprising ten or more of the recited amino acids as modified release amino acids in the following weight parts: Amino Acid Weight Parts L-Alanine 2.0-7.0 L-Arginine 3.0-8.2 L-Aspartic Acid \u20025.0-10.5 L-Cystine 1.5-4.0 L-Glutamic Acid + 10.0-22.0 Glutamine Glycine 4.0-8.0 L-Hisitidine 2.5-5.0 L-Isoleucine 4.0-7.0 L-Leucine \u20028.0-14.0 L-Lysine 4.9-9.0 L-Methionine 1.0-3.0 L-Phenylalanine 4.5-7.0 L-Proline \u20024.0-10.0 L-Serine 3.0-7.0 L-Threonine 4.0-6.5 L-Tryptophan 1.5-3.0 L-Tyrosine \u20026.5-12.0 L-Valine 4.0-8.0 L-Carnitine 0.05-0.2\u2002 Taurine 0.1-0.7

Metadata:
- Claim Count in Document: 21.0
- Percentile: 90.0
- Lexical Diversity: 1.18519
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15655924', '12714181', '12433510', '10364793', '10943356']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6877016396140399
- 35 USC 102 Novelty (BERT): 0.5147213692939618
- Combined Prediction Score: 0.6704036125820321
- Mean Citation Score: 224.945836
- Max Citation Score: 259.45892000000003
- Similarity Product: 171.89197370477203

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test